Ads

 

Ads

 

Ads

 

Nasdaq Top Companies List by Market Cap as of January 2024

Nasdaq Top Companies List by Market Cap as of Jan-05-2024, Nasdaq Biggest 500 Companies List by Market Cap, Nasdaq Largest 500 Companies List by market cap as of Jan-05-2024.
Metatag Title
Nasdaq Largest and Top 1,000 Companies List in 2024
Metatag Abstract
Nasdaq Largest 1,000 Companies List by Market Cap in 2024, Nasdaq Top 1,000 Companies List by Market Cap in 2024.
  1. BayCom Corp.

    World Rank (Jan-05-2024)
    16,436
    Market Cap (Jan-05-2024)
    0.266 Billion USD
    World Rank (Jul-30-2023)
    16,948
    Market Cap (Jul-30-2023)
    0.246 Billion USD
    World Rank (Dec-25-2022)
    16,913
    Market Cap (Dec-25-2022)
    0.246 Billion USD
    World Rank (Jan-07-2022)
    18,866
    Market Cap (Jan-07-2022)
    0.21 Billion USD
    Annual Revenue in USD
    87 Million USD
    Annual Net Income in USD
    14 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  2. ALX Oncology Holdings Inc

    World Rank (Jan-05-2024)
    10,415
    Market Cap (Jan-05-2024)
    0.717 Billion USD
    World Rank (Jul-30-2023)
    16,993
    Market Cap (Jul-30-2023)
    0.243 Billion USD
    World Rank (Dec-25-2022)
    13,048
    Market Cap (Dec-25-2022)
    0.454 Billion USD
    World Rank (Jan-07-2022)
    10,788
    Market Cap (Jan-07-2022)
    0.78 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -83 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    ALX Oncology is a Clinical Stage Biotechnology company working on Immuno Oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system. The company annual revenue is approximately 185.7 million USD. The headquarters is in USA.
  3. Regencell Bioscience Holdings Ltd

    World Rank (Jan-05-2024)
    19,846
    Market Cap (Jan-05-2024)
    0.137 Billion USD
    World Rank (Jul-30-2023)
    16,994
    Market Cap (Jul-30-2023)
    0.243 Billion USD
    World Rank (Dec-25-2022)
    14,236
    Market Cap (Dec-25-2022)
    0.380 Billion USD
    World Rank (Jan-07-2022)
    14,583
    Market Cap (Jan-07-2022)
    0.42 Billion USD
    Headquarters Country
  4. Eagle Pharmaceuticals

    World Rank (Jan-05-2024)
    23,340
    Market Cap (Jan-05-2024)
    0.068 Billion USD
    World Rank (Jul-30-2023)
    16,995
    Market Cap (Jul-30-2023)
    0.243 Billion USD
    World Rank (Dec-25-2022)
    14,240
    Market Cap (Dec-25-2022)
    0.379 Billion USD
    World Rank (Jan-07-2022)
    11,839
    Market Cap (Jan-07-2022)
    0.65 Billion USD
    Annual Revenue in USD
    171 Million USD
    Annual Net Income in USD
    -8 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Eagle Pharmaceuticals is a Specialty Pharmaceutical company. It is working on advance safe and efficient injectable treatments for patients across oncology, critical care and orphan diseases. The company annual revenue is 195.9 million USD and 108 employees as on 2019. The headquarters is in USA.
  5. Southern First Bancshares

    World Rank (Jan-05-2024)
    15,787
    Market Cap (Jan-05-2024)
    0.299 Billion USD
    World Rank (Jul-30-2023)
    17,019
    Market Cap (Jul-30-2023)
    0.242 Billion USD
    World Rank (Dec-25-2022)
    14,450
    Market Cap (Dec-25-2022)
    0.367 Billion USD
    World Rank (Jan-07-2022)
    13,280
    Market Cap (Jan-07-2022)
    0.52 Billion USD
    Annual Revenue in USD
    96 Million USD
    Annual Net Income in USD
    46 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
  6. Verrica Pharmaceuticals

    World Rank (Jan-05-2024)
    16,042
    Market Cap (Jan-05-2024)
    0.286 Billion USD
    World Rank (Jul-30-2023)
    17,040
    Market Cap (Jul-30-2023)
    0.242 Billion USD
    World Rank (Dec-25-2022)
    21,504
    Market Cap (Dec-25-2022)
    0.103 Billion USD
    World Rank (Jan-07-2022)
    17,721
    Market Cap (Jan-07-2022)
    0.25 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -43 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  7. Inflarx

    World Rank (Jan-05-2024)
    21,019
    Market Cap (Jan-05-2024)
    0.108 Billion USD
    World Rank (Jul-30-2023)
    17,056
    Market Cap (Jul-30-2023)
    0.241 Billion USD
    World Rank (Dec-25-2022)
    19,780
    Market Cap (Dec-25-2022)
    0.144 Billion USD
    World Rank (Jan-07-2022)
    20,092
    Market Cap (Jan-07-2022)
    0.17 Billion USD
    Headquarters Country
  8. PDL Community Bancorp

    World Rank (Jan-05-2024)
    17,480
    Market Cap (Jan-05-2024)
    0.217 Billion USD
    World Rank (Jul-30-2023)
    17,073
    Market Cap (Jul-30-2023)
    0.240 Billion USD
    World Rank (Dec-25-2022)
    17,174
    Market Cap (Dec-25-2022)
    0.235 Billion USD
    World Rank (Jan-07-2022)
    17,854
    Market Cap (Jan-07-2022)
    0.25 Billion USD
    Annual Revenue in USD
    54 Million USD
    Annual Net Income in USD
    4 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  9. AC Immune SA

    World Rank (Jan-05-2024)
    13,356
    Market Cap (Jan-05-2024)
    0.443 Billion USD
    World Rank (Jul-30-2023)
    17,083
    Market Cap (Jul-30-2023)
    0.240 Billion USD
    World Rank (Dec-25-2022)
    19,687
    Market Cap (Dec-25-2022)
    0.146 Billion USD
    World Rank (Jan-07-2022)
    15,664
    Market Cap (Jan-07-2022)
    0.35 Billion USD
    Annual Revenue in USD
    18 Million USD
    Annual Net Income in USD
    -71 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
  10. Fulcrum Therapeutics

    World Rank (Jan-05-2024)
    13,136
    Market Cap (Jan-05-2024)
    0.458 Billion USD
    World Rank (Jul-30-2023)
    17,105
    Market Cap (Jul-30-2023)
    0.238 Billion USD
    World Rank (Dec-25-2022)
    15,206
    Market Cap (Dec-25-2022)
    0.325 Billion USD
    World Rank (Jan-07-2022)
    12,092
    Market Cap (Jan-07-2022)
    0.62 Billion USD
    Annual Revenue in USD
    19 Million USD
    Annual Net Income in USD
    -80 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Fulcrum Therapeutics is a Clinical Stage Biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need with an initial focus on rare diseases. The company annual revenue is 8.82 million USD and 432 employees as on 2020. The headquarters is in USA.

Share

Ads